Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M9FT
|
|||
| Former ID |
DIB005555
|
|||
| Drug Name |
Omniferon
|
|||
| Synonyms |
Alpha Leukoferon; Human alpha interferon, Viragen; Leukocyte-derived interferon; Alpha-IFN, Viragen; Topically enhanced Onmiferon (genital herpes), Viragen/Zonagen; BST-GEL (Omniferon), Viragen/Biosyntech
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Terminated | [1] | |
| Company |
Viragen Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Interferon receptor (IFNR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011081) | |||
| REF 2 | US patent application no. 2004,0229,936, Treatment of hepatitis c virus infection with sesquiterpene lactones. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.